Clinical Recommendation on Fertility Preservation in Borderline Ovarian Neoplasm: Ovarian Stimulation and Oocyte Retrieval after Conservative Surgery

被引:27
作者
Denschlag, Dominik [1 ]
von Wolff, Michael
Amant, Frederic
Kesic, Vesna
Reed, Nicholas
Schneider, Achim
Rodolakis, Alexandros
机构
[1] Univ Freiburg, Sch Med, Dept Obstet & Gynecol, DE-79106 Freiburg, Germany
关键词
Tumor; borderline; Neoplasm; ovarian; Ovarian stimulation; Oocyte retrieval; INFERTILITY TREATMENT; VITRO FERTILIZATION; TUMORS; MANAGEMENT; WOMEN; INDUCTION; CARCINOMA; OVULATION; OUTCOMES; CANCER;
D O I
10.1159/000316264
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Aim: To evaluate safety and fertility outcome after assisted conception in patients who were treated conservatively for a borderline ovarian tumor (BOT). Methods: A systematic literature review using Medline was conducted. From all the relevant case series the following information was obtained for each reported patient: primary diagnosis; disease stage; surgical treatment; duration of follow-up; incidence of recurrence; current disease status; the number of controlled ovarian stimulation cycles and/or oocyte retrievals, and successful pregnancies. Results: Overall 588 articles were screened, of which finally 15 reports including 62 patients met the inclusion criteria. Within a median follow-up duration of 52 months in this small group of patients, overall 12 patients (19.4%) had recurrences, and those recurrences were again successfully treated by surgery in 11 patients. In terms of assisted reproductive outcome, in our series overall 152 ovarian stimulation cycles as well as 135 oocyte retrievals were performed with a baby-take-home rate of 28.3% per stimulated cycle. Conclusion: It is mandatory to counsel all patients with a history of BOT who are seeking treatment for infertility that, due to the limited data, it is unclear whether assisted reproductive techniques are associated with an increased risk of recurrence. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码:160 / 165
页数:6
相关论文
共 34 条
  • [1] Evolutive peritoneal disease after conservative management and the use of infertility drugs in a patient with stage IIIC borderline micro-papillary serous carcinoma (MPSC) of the ovary: Case report
    Attar, E
    Berkman, S
    Topuz, S
    Baysal, B
    Akhan, S
    Chambers, JT
    [J]. HUMAN REPRODUCTION, 2004, 19 (06) : 1472 - 1475
  • [2] Beiner ME, 2001, CANCER-AM CANCER SOC, V92, P320, DOI 10.1002/1097-0142(20010715)92:2<320::AID-CNCR1325>3.0.CO
  • [3] 2-G
  • [4] Management of borderline ovarian neoplasms
    Cadron, Isabelle
    Leunen, Karin
    Van Gorp, Toon
    Amant, Frederic
    Neven, Patrick
    Vergote, Ignace
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (20) : 2928 - 2937
  • [5] Camatte S, 2002, BJOG-INT J OBSTET GY, V109, P376, DOI 10.1016/S1470-0328(02)01359-9
  • [6] Chan JK, 2003, J REPROD MED, V48, P756
  • [7] Ovulation induction treatment and risk of borderline ovarian tumors
    Cusido, Maite
    Fabregas, Rafael
    Barris, Pere S.
    Escayola, Cecilia
    Barri, Pere Nolsac
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2007, 23 (07) : 373 - 376
  • [8] Safety and efficacy of infertility treatment after conservative management of borderline ovarian tumors: a preliminary report
    Fasouliotis, SJ
    Davis, O
    Schattman, G
    Spandorfer, SD
    Kligman, I
    Rosenwaks, Z
    [J]. FERTILITY AND STERILITY, 2004, 82 (03) : 568 - 572
  • [9] Fertility after conservative treatment for borderline ovarian tumors:: a French multicenter study
    Fauvet, R
    Poncelet, C
    Boccara, J
    Descamps, P
    Fondrinier, E
    Daraï, E
    [J]. FERTILITY AND STERILITY, 2005, 83 (02) : 284 - 290
  • [10] Restaging surgery for women with borderline ovarian tumors -: Results of a French multicenter study
    Fauvet, R
    Boccara, J
    Dufournet, C
    David-Montefiore, E
    Poncelet, C
    Daraï, E
    [J]. CANCER, 2004, 100 (06) : 1145 - 1151